Aminophylline and caffeine for reversal of adverse symptoms associated with regadenoson SPECT MPI.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2017Doran JA, Sajjad W, Schneider MD, et al.
抄録
cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。
MeSH
Administration, OralAgedAminophyllineCaffeineCardiotonic AgentsCausalityDrug InteractionsDrug-Related Side Effects and Adverse ReactionsExercise TestFemaleHumansIncidenceInjections, IntravenousMaleMiddle AgedMyocardial Perfusion ImagingNew YorkPurinesPyrazolesSurvival RateTomography, Emission-Computed, Single-PhotonTreatment OutcomeVasodilator Agents
DOI 10.1007/s12350-016-0452-0
PMID 27025843
原文・出典を見る →